Carton1mg (Carton1mg)
Prednisone Delayed Release Tablet, Delayed Release
Product Images NDC 43598-887
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Prednisone Delayed Release (NDC 43598-887). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr. Reddys Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Carton2mg (Carton2mg)
This text appears to be a medical information sheet for Prednisone tablets. It includes instructions on the dosage, administration, and precautions for using delayed-release tablets containing 2mg of prednisone. The text advises against crushing, dividing, or chewing the tablets and recommends swallowing them whole. It also provides details about the product, including the manufacturer (Dr Reddys) and the prescription requirements. It seems to be important for patients to follow the specific guidelines mentioned for the proper use of this medication.*
Chemical-structure (Chemical Structure)
Figure1 (Figure1)
This is not available.*
Figure2 (Figure2)
This text provides information about ACR20 responders (%) in a study involving 231 participants who received Prednisone delayed-release tablets along with a DMARD, compared to 119 participants who were on a placebo and DMARD. The ACR20 response rate is likely being evaluated as a measure of treatment effectiveness in managing a particular condition.*
Logo-drl (Logo Drl)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
